Visalytics
Visalytics
approved EB-2 (NIW)

Assistant Professor

Biomedical Science · India · 2024-10-31

Processing Time
7 days
Decision Date
2024-10-31
Location
Oklahoma
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to develop novel diagnostic and therapeutic approaches using extracellular vesicles (EVs) to identify new biomarkers and therapeutic targets for chronic inflammatory diseases. His work focuses on creating innovative cell-free drug delivery systems to improve treatment efficacy and outcomes for patients.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses chronic inflammatory diseases, which impose an immense healthcare burden on the United States.

2 Well-positioned to Advance the Endeavor Met

The petitioner's Ph.D., 607 citations, and NIH funding demonstrate his prominent standing and expertise in biomedical science.

3 Waiver Benefit Met

The petitioner's contributions to the pharmaceutical drug delivery market and healthcare efficacy justify waiving the labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in Biomedical Sciences and a strong record of 12 peer-reviewed journal articles, 2 conference articles, and 15 first-authored abstracts. His work has garnered 607 citations and he has completed 9 peer reviews, demonstrating significant influence in his field. The case was further supported by 2 expert recommendation letters and evidence of funding from the National Institute of Health (NIH).

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Conference Presentations
Judging Experience
Government Alignment

Similar Cases

Clinical Research Coordinator

Biotechnology · Pakistan

WeGreened EB-2 (NIW) approved
Michigan 47 days 2025-05-12
The petitioner proposes to advance disease prevention and treatment strategies, specifically focusing on inflammatory bowel disease, heart disease, autoimmune disorders, and novel infections. The work involves optimizing and synthesizing predictive, therapeutic, and diagnostic modalities to improve clinical outcomes for pressing health issues.
View Case

Postdoctoral Researcher

Biotechnology · Venezuela

WeGreened EB-2 (NIW) approved
Maryland 44 days 2023-02-22
The petitioner proposes to continue testing new drugs using spectral flow cytometry, extracellular vesicle isolation, and Western blotting to determine molecular mechanisms of various health conditions like inflammatory cardiovascular diseases. The work aims to develop novel treatments and create new ways to screen for patient receptiveness to immunotherapy, reducing the reliance on chemotherapy.
View Case

Scientist

Biotechnology · Australia

WeGreened EB-2 (NIW) approved
Texas 55 days 2022-03-25
The petitioner proposes to enhance cell-based therapies in preclinical and clinical stages by developing high-throughput technologies to assess and identify immune cells with a high degree of accuracy. This work focuses on advancing cancer therapeutics by elucidating the role of extracellular vesicles (EVs) in cancer metastasis.
View Case

Scientist

Pharmaceuticals · India

WeGreened EB-2 (NIW) approved
Massachusetts 13 days 2021-12-20
The petitioner proposes to develop safe and effective drug delivery platforms, including lipid-based nanoparticles, extracellular vesicles, oral biotherapeutics, and hydrogels. This work utilizes techniques such as microfluidics and high-performance liquid chromatography to facilitate improved targeting and dosage for treating rheumatoid arthritis, diabetes, and cancer.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2024-10-31.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 7 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist